Evaluating the Effects of SCENAR Device Therapy Compared to Sham Treatment for Adults with Chronic Non-specific Neck Pain

What this Trial Is About

Chronic neck pain, a common condition causing disability and reduced mobility, often relies on medication-based treatments. However, non-drug therapies are recommended but underused due to limited evidence and awareness. This trial evaluates the SCENAR device, an electrotherapy tool delivering electrical impulses through the skin, to assess its impact on pain, function, and disability in adults with chronic non-specific neck pain. Participants will receive either five sessions of active SCENAR therapy or sham therapy applied to the painful cervical area. Each session lasts about 20 minutes, with intensity adjusted by patient feedback in the active group, while the sham group receives the device without electrical stimulation. The study compares these two approaches over approximately 10 weeks, including treatment and follow-up. During the trial, participants will be assessed for changes in their Neck Disability Index score, pain intensity at rest and during movement, and overall impression of change. Researchers will also monitor treatment adherence and evaluate psychological and social factors at baseline. Follow-up occurs two weeks after the last treatment session, with total participation lasting around 10 weeks to measure outcomes and safety.

SCENAR Therapy in Chronic Non-specific Neck Pain